These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2323155)

  • 21. Modelling acute tolerance to the EEG effect of two benzodiazepines.
    Ihmsen H; Albrecht S; Hering W; Schüttler J; Schwilden H
    Br J Clin Pharmacol; 2004 Feb; 57(2):153-61. PubMed ID: 14748814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rate of change of blood concentrations is a major determinant of the pharmacodynamics of midazolam in rats.
    Cleton A; Mazee D; Voskuyl RA; Danhof M
    Br J Pharmacol; 1999 May; 127(1):227-35. PubMed ID: 10369477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intranasal midazolam: pharmacokinetics and pharmacodynamics assessed by quantitative EEG in healthy volunteers.
    Hardmeier M; Zimmermann R; Rüegg S; Pflüger M; Deuster S; Suter K; Donzelli M; Drewe J; Krähenbühl S; Fuhr P; Haschke M
    Clin Pharmacol Ther; 2012 May; 91(5):856-62. PubMed ID: 22453191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A population analysis of the pharmacokinetics and pharmacodynamics of midazolam in the rat.
    Aarons L; Mandema JW; Danhof M
    J Pharmacokinet Biopharm; 1991 Oct; 19(5):485-96. PubMed ID: 1783988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of the concentration-effect relationships of midazolam for EEG-derived parameters and saccadic peak velocity.
    Van Steveninck AL; Mandema JW; Tuk B; Van Dijk JG; Schoemaker HC; Danhof M; Cohen AF
    Br J Clin Pharmacol; 1993 Aug; 36(2):109-15. PubMed ID: 8398578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of 7-day exposure to midazolam on electroencephalogram pharmacodynamics in rats: a model to study multiple pharmacokinetic-pharmacodynamic relationships in individual animals.
    Laurijssens BE; Greenblatt DJ
    J Pharm Pharmacol; 2002 Jan; 54(1):77-86. PubMed ID: 11829133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic-pharmacodynamic modelling of the EEG effect of alfentanil in rats.
    Cox EH; Van Hemert JG; Tukker EJ; Danhof M
    J Pharmacol Toxicol Methods; 1997 Oct; 38(2):99-108. PubMed ID: 9403781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacodynamic analysis of the interaction between tiagabine and midazolam with an allosteric model that incorporates signal transduction.
    Jonker DM; Vermeij DA; Edelbroek PM; Voskuyl RA; Piotrovsky VK; Danhof M
    Epilepsia; 2003 Mar; 44(3):329-38. PubMed ID: 12614388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
    Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic-pharmacodynamic modeling of the electroencephalographic effects of benzodiazepines. Correlation with receptor binding and anticonvulsant activity.
    Mandema JW; Sansom LN; Dios-Vièitez MC; Hollander-Jansen M; Danhof M
    J Pharmacol Exp Ther; 1991 Apr; 257(1):472-8. PubMed ID: 1850477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [RO 48-6791--a short acting benzodiazepine. Pharmacokinetics and pharmacodynamics in young and old subjects in comparison to midazolam].
    Hering W; Ihmsen H; Albrecht S; Schwilden H; Schüttler J
    Anaesthesist; 1996 Dec; 45(12):1211-4. PubMed ID: 9065257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and pharmacodynamics of midazolam after intranasal administration.
    Burstein AH; Modica R; Hatton M; Forrest A; Gengo FM
    J Clin Pharmacol; 1997 Aug; 37(8):711-8. PubMed ID: 9378843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous modeling of the pharmacokinetics and pharmacodynamics of midazolam and diazepam.
    Mould DR; DeFeo TM; Reele S; Milla G; Limjuco R; Crews T; Choma N; Patel IH
    Clin Pharmacol Ther; 1995 Jul; 58(1):35-43. PubMed ID: 7628181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated pharmacokinetics and pharmacodynamics of Ro 48-6791, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects.
    Dingemanse J; van Gerven JM; Schoemaker RC; Roncari G; Oberyé JJ; van Oostenbruggen MF; Massarella J; Segala P; Zell M; Cohen AF
    Br J Clin Pharmacol; 1997 Nov; 44(5):477-86. PubMed ID: 9384465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of midazolam and sarmazenil on the equine electroencephalogram during anaesthesia with halothane in oxygen.
    Johnson CB; Bloomfield M; Taylor PM
    J Vet Pharmacol Ther; 2003 Apr; 26(2):105-12. PubMed ID: 12667179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism-based modeling of the pharmacodynamic interaction of alphaxalone and midazolam in rats.
    Visser SA; Huntjens DR; van der Graaf PH; Peletier LA; Danhof M
    J Pharmacol Exp Ther; 2003 Nov; 307(2):765-75. PubMed ID: 12975494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intranasal administration of midazolam: pharmacokinetic and pharmacodynamic properties and sedative potential.
    Fukuta O; Braham RL; Yanase H; Kurosu K
    ASDC J Dent Child; 1997; 64(2):89-98. PubMed ID: 9188997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A population pharmacokinetic/pharmacodynamic analysis of regadenoson, an adenosine A2A-receptor agonist, in healthy male volunteers.
    Gordi T; Frohna P; Sun HL; Wolff A; Belardinelli L; Lieu H
    Clin Pharmacokinet; 2006; 45(12):1201-12. PubMed ID: 17112296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic and pharmacodynamic study of midazolam in children during esophagogastroduodenoscopy.
    Tolia V; Brennan S; Aravind MK; Kauffman RE
    J Pediatr; 1991 Sep; 119(3):467-71. PubMed ID: 1880665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relevance of arteriovenous concentration differences in pharmacokinetic-pharmacodynamic modeling of midazolam.
    Tuk B; Herben VM; Mandema JW; Danhof M
    J Pharmacol Exp Ther; 1998 Jan; 284(1):202-7. PubMed ID: 9435179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.